Neptune, Aker BioMarine Bury Patent Hatchet
This article was originally published in The Rose Sheet
Executive Summary
The firms say their patent cross-licensing agreement ends all outstanding litigation. Aker gets access to Neptune's composition patents for $10m over a period of 15 months, and Neptune has rights to Aker's select krill oil-related patent portfolio for $4m.